Related Experiment Video
Updated: Jan 27, 2026

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
Three novel MTM1 pathogenic variants identified in Japanese patients with X-linked myotubular myopathy
Atsuko Nishikawa1, Aritoshi Iida2, Shinichiro Hayashi1
1Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan.
Background:
X-linked myotubular myopathy (XLMTM) is a form of the severest congenital muscle diseases characterized by marked muscle weakness, hypotonia, and feeding and breathing difficulties in male infants. It is caused by mutations in the myotubularin gene (MTM1).
Methods:
Evaluation of clinical history and examination of muscle pathology of three patients and comprehensive genome analysis on our original targeted gene panel system for muscular diseases.
Results:
We report three patients, each of whom presents distinct muscle pathological features. The three patients have novel hemizygous MTM1 variants, including c.527A>G (p.Gln176Arg), c.595C>G (p.Pro199Ala), or c.688T>C (p.Trp230Arg).
Conclusions:
All variants were assessed as "Class 4 (likely pathogenic)" on the basis of the guideline of American College of Medical Genetics and Genomics. These distinct pathological features among the patients with variants in the second cluster of PTP domain in MTM1 provides an insight into microheterogeneities in disease phenotypes in XLMTM.
Insights
X-linked myotubular myopathy (XLMTM), a severe congenital muscle disease, is caused by MTM1 gene mutations. Novel variants in male infants reveal distinct pathological features, offering insights into disease variations.
Area of Science:
- Genetics
- Neuromuscular Disorders
- Molecular Biology
Background:
- X-linked myotubular myopathy (XLMTM) is a severe congenital muscle disease affecting male infants.
- Characterized by profound muscle weakness, hypotonia, and challenges with feeding and breathing.
- Caused by mutations in the myotubularin gene (MTM1).
Observation:
- Three male infants with distinct muscle pathological features were studied.
- Comprehensive genome analysis was performed using a targeted gene panel system.
- Clinical history and muscle pathology were evaluated.
Findings:
- Three novel hemizygous MTM1 variants (c.527A>G, c.595C>G, c.688T>C) were identified.
- These variants were classified as Class 4 (likely pathogenic) according to ACMG guidelines.
- Patients exhibited distinct muscle pathological features despite MTM1 variants.
Implications:
- The identified MTM1 variants provide new genetic insights into XLMTM.
- Distinct pathological features associated with MTM1 variants suggest microheterogeneity in disease presentation.
- Findings contribute to understanding the spectrum of XLMTM phenotypes.
Related Concept Videos
Histone Variants at the Centromere
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
X-linked Traits
Sex-linked Disorders
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Defenses Against Pathogens and Herbivores

